Clínic-IDIBAPS optimizes its academic CAR-T therapy against multiple myeloma to address relapse
Researchers from Clínic-IDIBAPS, as part of the Clínic Barcelona Comprehensive Cancer Centre — a centre driven by Clínic, IDIBAPS and the Universit...
Service News from Hematología
Hospital Clínic marks 25 years of home-based haematology care
The Home Care Unit (UAD) of the Clínic Barcelona Comprehensive Cancer Centre marked its 25th anniversary on 5 March 2026 with a commemorative event...
CAR-T ARI-0001 shows high response rates in adult patients with acute lymphoblastic leukemia
Developed by Clínic-IDIBAPS teams as part of the Clínic Barcelona Comprehensive Cancer Centre, this treatment confirms its therapeutic potential in...
Clínic Barcelona Comprehensive Cancer Centre highlights 2025 achievements on World Cancer Day
On World Cancer Day, held every year on 4 February, Clínic Barcelona Comprehensive Cancer Centre (4CB) highlights its excellence in patient care an...
Clínic Barcelona ranks as the third best public hospital in Spain according to the Merco Salud 2025 ranking
The hospital, which has also been recognized as the best public hospital in Catalonia, stands out with five services ranked first: Digestive System...
Innovations in transplants and advanced therapies: key contributions from the Clínic Barcelona Comprehensive Cancer Centre at ASH 2025
Hospital Clínic Barcelona and IDIBAPS, through the Clínic Barcelona Comprehensive Cancer Centre (4CB), had a prominent presence at the ASH 2025 Ann...
OECI conducts an audit at Clínic Barcelona Comprehensive Cancer Centre
On November 26 and 27, a team from the Organisation of European Cancer Institutes (OECI) conducted an audit at the Clínic Barcelona Comprehensive C...
C17 hospitals launch an integrated network for cancer care
Hospitals that are part of the C17 alliance have launched the C17 Integrated Cancer Network (XIC-C17), an initiative aimed at strengthening coordin...
An experimental new CAR-T therapy shows high efficacy in multiple myeloma, even against treatment resistance
A study led by the Clínic Barcelona Comprehensive Cancer Center —a center driven by Clínic-IDIBAPS and the University of Barcelona (UB)— demonstrat...
A new CAR-T therapy shows efficacy in preclinical models of hard-to-treat leukemias
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a st...